Covaris Receives the Society for Laboratory Automation and Screening (SLAS) New Product Award at LabAutomation 2011February 8, 2011
Covaris Signs Co-Marketing Agreement with Illumina to Combine Next-Gen Sequencing Platforms with Controlled DNA ShearingSeptember 10, 2010
Tecan and Covaris Co-Market Freedom EVO® with Adaptive Focused Acoustics™
Männedorf, Switzerland—November 18, 2010—Tecan is collaborating with Covaris, Inc., a rapidly growing company providing advanced sample preparation solutions for life and analytical science, to copromote the Freedom EVO® liquid handling platform with integrated Adaptive Focused Acoustics™ (AFA). This co-marketing agreement will allow customers to benefit from both the advanced capabilities of Tecan’s Freedom EVO systems and Covaris’ controlled non-contact acoustic sample preparation technology.
Covaris’ AFA systems have already been successfully integrated into the Freedom EVO platform for several applications, and this joint offering will now be available to customers worldwide for sample preparation, compound management and next generation sequencing applications.
Kevin Moore, Tecan’s Director of Market and Application Management for BioPharma, said: “AFA is gaining widespread acceptance in the compound management community for rapid thawing, mixing and dissolution of samples, as well as for DNA shearing in the exciting area of next generation sequencing. We are extremely pleased to be working together with Covaris to provide valuable automated solutions to our customers working in these areas.”
“Covaris is delighted to enter into partnership with Tecan to provide researchers with next generation automated sample preparation,” said Jim Laugharn, Covaris President and CEO. “High quality, reproducible sample preparation is the critical first step in improving analytical results, and Covaris’ highly controlled system sets the standard for today’s rapidly advancing analytical technologies and sophisticated assays. This collaboration between Tecan and Covaris provides scalable, turn-key automated sample preparation solutions for a wide variety of key life science applications.”
To find out more on Tecan’s Freedom EVO workstations, visit http://www.tecan.com/freedomevo
To find out more about our solution, visit http://www.tecan.com/covaris
To find out more on Covaris’ Adaptive Focused Acoustics, visit https://www.covaris.com
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. As an original equipment manufacturer, Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2009, Tecan generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN CH0012100191).
About Covaris, Inc.
Covaris, Inc. (www.covaris.com) provides advanced sample preparation systems for life and analytical sciences. We design, manufacture, and distribute products that support a wide variety of applications including next-generation DNA sequencing, ChIP, proteomics, and compound management. Our patented Adaptive Focused Acoustic (AFA) technology brings unsurpassed speed and efficiency to sample preparation. The AFA process, which is based on shock wave physics, delivers controlled, precise and accurate acoustic energy to biological and chemical samples. Covaris sells instruments in more than 30 countries throughout the world.